{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Lake Forest",
      "state": "IL",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "77687",
      "recalling_firm": "Hospira Inc., A Pfizer Company",
      "address_1": "275 N Field Dr",
      "address_2": "N/A",
      "postal_code": "60045-2579",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0980-2017",
      "product_description": "Argatroban Injection, 250 mg/2.5 mL (100 mg/mL), 5 mL Single-use vial, Rx Only, Sterile, Manufactured by: Gland Pharma Limited, Hyderabad, India,  Manufactured for:  Hospira, Inc, Lake Forest, IL 60045 ---  NDC  0409-1140-01",
      "product_quantity": "701 vials",
      "reason_for_recall": "Failed Impurities/Degradation Specifications; out of specification result for denitroquinoline-related impurity during three month time point",
      "recall_initiation_date": "20170706",
      "center_classification_date": "20170714",
      "termination_date": "20190910",
      "report_date": "20170726",
      "code_info": "Lot:  DP601, exp 10/2018"
    }
  ]
}